Assessment of efficacy of Lorlatinib in patients with metastatic Non small cell Lung cancer pretreated ALK/ROS1-positive in from the German early access program
Latest Information Update: 14 Oct 2020
At a glance
- Drugs Lorlatinib (Primary)
- Indications Adenocarcinoma; Non-small cell lung cancer
- Focus Therapeutic Use
- 14 Oct 2020 New trial record
- 21 Sep 2020 Results presented at the 45th European Society for Medical Oncology Congress